Tuesday, October 18, 2016 8:31:58 AM
CBIO - .99 Pre-market inching up.
Catalyst Biosciences Announces Agreement to Sell NNR Asset For $750K, With Potential To Receive $337M In Development, Regulatory, and Commercial Milestone Payments
Catalyst Biosciences Announces Agreement to Sell NNR Asset For $750K, With Potential To Receive $337M In Development, Regulatory, and Commercial Milestone Payments
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
